Alcohol
Volume 24, Issue 2 , Pages 129-135 , June 2001

Genetic analysis of the μ-opioid receptor in alcohol-dependent individuals

  • Hans Rommelspacher

      Affiliations

    • Departments of Clinical Neurobiology and Psychiatry, Free University, Ulmenallee 32, 14050 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Department of Clinical Neurobiology, Free University, Ulmenallee 32, 14050 Berlin, Germany. Tel.: +49-30-8445-8234; fax: +49-30-8445-8244
    • ,
  • Michael Smolka

      Affiliations

    • Departments of Clinical Neurobiology and Psychiatry, Free University, Ulmenallee 32, 14050 Berlin, Germany
    • ,
  • Lutz G Schmidt

      Affiliations

    • Departments of Clinical Neurobiology and Psychiatry, Free University, Ulmenallee 32, 14050 Berlin, Germany
    • ,
  • Jerzy Samochowiec

      Affiliations

    • Department of Psychiatry, Pomeranian Medical University, Ul. Broniewskiego 26, 71-460 Szczecin, Poland
    • ,
  • Margret R Hoehe

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine Robert-Rössle-Str. 10, 13092 Berlin, Germany

Received 25 September 2000 ,Revised 5 December 2000 ,Accepted 11 February 2001.

References 

  1. Benjamin D, Grant ER, Pohorecky LA. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 1993;621:137–140
  2. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry. 1997;2:490–494
  3. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998;95:9608–9613
  4. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573–588
  5. Cloninger CR, Pryzbeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep. 1991;69:1047–1057
  6. de Waele J-P, Gianoulakis C. Effects of single and repeated exposures to ethanol on hypothalamic β-endorphin and CRH release by the C57BL/6 and DBA/2 strains of mice. Neuroendocrinology. 1993;57:700–709
  7. Dufeu P, Kuhn S, Schmidt LG. Validity and reliability of a German version of Cloninger's Tridimensional Personality Questionnaire (TPQ) by alcoholics. Sucht. 1995;41:395–407
  8. Dupont A, Cusan L, Garon M, Labrie F, Li CH. β-endorphin: stimulation of growth hormone release in vivo. Proc Natl Acad Sci USA. 1977;74:358–359
  9. Gianoulakis C, Béliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V, et al. Different pituitary β-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci. 1989;45:1097–1109
  10. Gscheidel N, Sander T, Wendel B, Heere P, Schmidt LG, Rommelspacher H, et al. Five exon 1 variants of μ opioid receptor and vulnerability to alcohol dependence. Pol J Pharmacol. 2000;52:27–31
  11. Hoehe MR, Köpke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, et al. Sequence variability and candidate gene analysis in complex disease: association of μ opioid receptor gene variation with substance dependence. Hum Mol Genet. 2000;9:2895–2908
  12. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242:715–723
  13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215
  14. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology. 1998;50:1428–1432
  15. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992;49:881–887
  16. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236–1238
  17. Peroutka SJ. Genetic basis of migraine. Clin Neurosci. 1998;5:34–37
  18. Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P, et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet. 1998;81:207–215
  19. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069–1077
  20. Rommelspacher H, Raeder C, Kaulen P, Brüning G. Adaptive changes of dopamine-D2 receptors in rat brain following ethanol withdrawal: a quantitative autoradiographic investigation. Alcohol. 1992;9:355–362
  21. Sander T, Gscheidel N, Wendel B, Samochowiec J, Smolka M, Rommelspacher H, et al. Human μ-opioid receptor variation and alcohol dependence. Alcohol Clin Exp Res. 1998;22:2108–2110
  22. Smolka M, Sander T, Schmidt LG, Samochowiec J, Rommelspacher H, Gscheidel N, et al. μ-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinology. 1999;24:629–638
  23. Soini SL, Honkanen A, Hyytiä P, Korpi ER. [3H]ethylketocyclazocine binding to brain opioid receptor subtypes in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. 1999;18:24–34
  24. Soini SL, Ovaska T, Honkanen A, Hyytiä P, Korpi ER. Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. 1998;15:227–232
  25. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, et al. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA. 1997;94:1544–1549
  26. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353–1357
  27. Szpir M. Alcoholism, personality and dopamine. Am Scientist. 1995;83:425–426
  28. Uhl GR, Sora I, Wang Z. The μ opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA. 1999;96:7752–7755
  29. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880
  30. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR. Mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA. 1993;90:10230–10234
  31. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 1994;338:217–222
  32. Wendel B, Hoehe MR. The human μ opioid receptor gene: 5′ regulatory and intronic sequences. J Mol Med. 1998;76:525–532
  33. Widdowson PS, Holman RB. Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates. J Neurochem. 1992;59:157–163
  34. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–492
  35. World Health Organization . International Classification of Diseases: Clinical Descriptions and Diagnostic Guidelines. 10th edition, rev.. Geneva, Switzerland: Author; 1992;
  36. Ziegler DK, Hur YM, Bouchard TJ, Hassanein RS, Barter R. Migraine in twins raised together and apart. Headache. 1998;38:417–422

PII: S0741-8329(01)00139-2

Alcohol
Volume 24, Issue 2 , Pages 129-135 , June 2001

Article Tools

* Image Usage & Resolution